share_log

皓元医药(688131.SH):以债转股方式对全资子公司增资2亿元

Haoyuan Pharmaceutical (688131.SH): Capital increase of 200 million yuan for wholly-owned subsidiary through debt-to-equity swaps

Gelonghui Finance ·  Mar 22 18:40

Gelonghui, March 22丨Haoyuan Pharmaceutical (688131.SH) announced that on March 22, 2024, the company held the 34th meeting of the 3rd board of directors and the 32nd meeting of the 3rd board of supervisors to review and pass the “Proposal on Increasing the Capital of Wholly-owned Subsidiaries by using debt-for-equity swaps”, and agreed that the company would use funds raised to increase the capital of Anhui Haoyuan by RMB 20.00 million. After the capital increase was completed, the registered capital of Anhui Haoyuan increased from RMB 20 million to RMB 40 million. It is a wholly-owned subsidiary of the company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment